BROADCASTS.com

So my friend, Justin Morgenstern recently put up a post on Idarucizumab, aka Praxbind. He seemed pretty fired up on the issue, so I got him on the line to talk about it. What follows is a conversation on evidence and what to do when there is not a good amount of it. Schtuff The EM Cases Podcast that partially sparked the debate Justin Wrote an Additional Post after our Discussion On Parachutes and Such On to the Wee...